NovaBay Pharmaceuticals Inc (NBY)
0.0745
0.00 (0.00%)
USD |
NYAM |
Apr 24, 16:00
0.0721
0.00 (0.00%)
After-Hours: 20:00
NovaBay Pharmaceuticals Enterprise Value: 2.275M for April 23, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 2.275M |
| April 22, 2024 | 2.139M |
| April 19, 2024 | 2.437M |
| April 18, 2024 | 2.485M |
| April 17, 2024 | 2.452M |
| April 16, 2024 | 2.350M |
| April 15, 2024 | 2.41M |
| April 12, 2024 | 2.678M |
| April 11, 2024 | 2.654M |
| April 10, 2024 | 2.711M |
| April 09, 2024 | 2.572M |
| April 08, 2024 | 2.729M |
| April 05, 2024 | 3.000M |
| April 04, 2024 | 3.105M |
| April 03, 2024 | 3.096M |
| April 02, 2024 | 3.093M |
| April 01, 2024 | 3.114M |
| March 28, 2024 | 3.108M |
| March 27, 2024 | 3.304M |
| March 26, 2024 | 4.141M |
| March 25, 2024 | 3.837M |
| March 22, 2024 | 4.056M |
| March 21, 2024 | 4.086M |
| March 20, 2024 | 4.171M |
| March 19, 2024 | 4.111M |
| Date | Value |
|---|---|
| March 18, 2024 | 4.171M |
| March 15, 2024 | 4.171M |
| March 14, 2024 | 4.011M |
| March 13, 2024 | 4.219M |
| March 12, 2024 | 4.090M |
| March 11, 2024 | 1.533M |
| March 08, 2024 | 1.537M |
| March 07, 2024 | 1.554M |
| March 06, 2024 | 1.585M |
| March 05, 2024 | 1.619M |
| March 04, 2024 | 1.643M |
| March 01, 2024 | 1.670M |
| February 29, 2024 | 1.598M |
| February 28, 2024 | 1.688M |
| February 27, 2024 | 1.556M |
| February 26, 2024 | 1.634M |
| February 23, 2024 | 1.686M |
| February 22, 2024 | 1.675M |
| February 21, 2024 | 1.624M |
| February 20, 2024 | 1.731M |
| February 16, 2024 | 1.817M |
| February 15, 2024 | 1.743M |
| February 14, 2024 | 1.656M |
| February 13, 2024 | 1.497M |
| February 12, 2024 | 1.570M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-0.9337M
Minimum
Dec 27 2022
58.19M
Maximum
Jun 10 2019
12.32M
Average
10.51M
Median
Enterprise Value Benchmarks
| Eyenovia Inc | 25.15M |
| Palatin Technologies Inc | 18.75M |
| iBio Inc | 16.49M |
| Theriva Biologics Inc | -13.75M |
| Oragenics Inc | 3.306M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.108M |
| Revenue (Quarterly) | 3.727M |
| Total Expenses (Quarterly) | 4.525M |
| EPS Diluted (Quarterly) | -0.8165 |
| Gross Profit Margin (Quarterly) | 48.70% |
| Profit Margin (Quarterly) | -110.2% |
| Earnings Yield | -4.44K% |
| Normalized Earnings Yield | -4242.33 |